Q&A: Exploring AI-Inspired Patient Monitoring in Huntington's Disease Drug Development

AI-driven patient monitoring is advancing Huntington's disease drug development by enabling long-term, real-world data collection that captures subtle disease progression and heterogeneity. Digital health technologies could detect early-stage symptoms and complement traditional biomarkers, though challenges remain in validation, regulatory acceptance, and data privacy.

This Wire brief sits within Fusion42's coverage of Digital Health.